Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights on February 26, 2025

Company Overview - Relay Therapeutics is a clinical-stage precision medicine company focused on transforming the drug discovery process through advanced computational and experimental technologies [2] - The company aims to develop life-changing therapies, particularly in targeted oncology and genetic disease indications [2] Financial Reporting - Relay Therapeutics will report its fourth quarter and full year 2024 financial results and corporate highlights on February 26, 2025, after U.S. financial markets close [1] Technology and Innovation - The company's Dynamo platform integrates various leading-edge computational and experimental approaches to target previously challenging protein targets in drug discovery [2] - Relay Therapeutics represents a new breed of biotech that combines complementary techniques and technologies to push the boundaries of drug discovery [2]